Does Ultrasound-guided Suprascapular Nerve Block Provide Additional

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

See also
Status	Clinical Trial	Phase
Completed	`NCT04398589` - The Effect of Dexmedetomidine for Suprascapular Nerve Block With Axillary Nerve Block	Phase 4
Completed	`NCT05442814` - Anterior and Posterior Approaches of Suprascapular Nerve Block	N/A
Completed	`NCT03277326` - Interscalene vs Anterior and Posterior Suprascapular Nerve Block for Shoulder Arthroscopic Surgeries	N/A
Completed	`NCT03212443` - Combined Suprascapular and Axillary Nerve Blocks for Arthroscopic Shoulder Surgery	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT04398589 - The Effect of Dexmedetomidine for Suprascapular Nerve Block With Axillary Nerve Block

Phase 4

Completed

NCT05442814 - Anterior and Posterior Approaches of Suprascapular Nerve Block

N/A

Completed

NCT03277326 - Interscalene vs Anterior and Posterior Suprascapular Nerve Block for Shoulder Arthroscopic Surgeries

N/A

Completed

NCT03212443 - Combined Suprascapular and Axillary Nerve Blocks for Arthroscopic Shoulder Surgery

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02776865
Study type	Interventional
Source	Taipei Veterans General Hospital, Taiwan
Contact	Jia chi Wang, MD
Email	jcwang0726@gmail.com
Status	Recruiting
Phase	N/A
Start date	October 2015

Does Ultrasound-guided Suprascapular Nerve Block Provide Additional Benefit Over Traditional Rehabilitation Program for Patients With Chronic Shoulder Pain — 2015/8/1

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms